Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LATS2 Antikörper (pSer83)

LATS2 Reaktivität: Human ELISA, WB Wirt: Maus Monoclonal ST-3B11 unconjugated
Produktnummer ABIN531847
  • Target Alle LATS2 Antikörper anzeigen
    LATS2 (LATS, Large Tumor Suppressor, Homolog 2 (Drosophila) (LATS2))
    Bindungsspezifität
    • 9
    • 8
    • 8
    • 7
    • 7
    • 7
    • 7
    • 7
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer83
    Reaktivität
    • 64
    • 55
    • 15
    • 4
    Human
    Wirt
    • 72
    • 1
    Maus
    Klonalität
    • 72
    • 1
    Monoklonal
    Konjugat
    • 20
    • 9
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    Dieser LATS2 Antikörper ist unkonjugiert
    Applikation
    • 31
    • 30
    • 13
    • 6
    • 4
    • 1
    • 1
    • 1
    • 1
    ELISA, Western Blotting (WB)
    Verwendungszweck
    Mouse monoclonal antibody raised against synthetic phosphopeptide of LATS2.
    Kreuzreaktivität
    Human
    Produktmerkmale
    Phospho-LATS2 Ser83 Antibody detects phosphorylated recombinat LATS2 only when phosphorylated at serine83, by western blotting.
    Immunogen
    Synthetic phosphopeptide (conjugated with KLH) corresponding to residues surrounding S83 of human LATS2.
    Klon
    ST-3B11
    Isotyp
    IgG2b
    Top Product
    Discover our top product LATS2 Primärantikörper
  • Applikationshinweise
    Western Blot (1-2 μg/mL)
    ELISA (1 μg/mL)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    In 10 mM HEPES/KOH, 150 mM NaCl, pH 7.5 (50 % glycerol)
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Zhang, Iyer, Chowdhury, Ji, Xiao, Yang, Chen, Tsai, Dong: "KIBRA regulates aurora kinase activity and is required for precise chromosome alignment during mitosis." in: The Journal of biological chemistry, Vol. 287, Issue 41, pp. 34069-77, (2012) (PubMed).

    Xu, Stamenkovic, Yu: "CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma." in: Cancer research, Vol. 70, Issue 6, pp. 2455-64, (2010) (PubMed).

    Lau, Murray, Houshmandi, Xu, Gutmann, Yu: "Merlin is a potent inhibitor of glioma growth." in: Cancer research, Vol. 68, Issue 14, pp. 5733-42, (2008) (PubMed).

  • Target
    LATS2 (LATS, Large Tumor Suppressor, Homolog 2 (Drosophila) (LATS2))
    Andere Bezeichnung
    LATS2 (LATS2 Produkte)
    Synonyme
    4932411G09Rik antikoerper, AV277261 antikoerper, AW228608 antikoerper, KPM antikoerper, lats2 antikoerper, large tumor suppressor kinase 2 antikoerper, large tumor suppressor 2 antikoerper, LATS2 antikoerper, Lats2 antikoerper, lats2 antikoerper
    Gen-ID
    26524
    NCBI Accession
    NM_014572
Sie sind hier:
Kundenservice